These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 31558356
21. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators. J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671 [Abstract] [Full Text] [Related]
22. Ventricular tachycardia and sudden cardiac death. Reddy PC, Tandon N, Stafford PR. J La State Med Soc; 1999 May 03; 151(5):281-7. PubMed ID: 10363484 [Abstract] [Full Text] [Related]
23. Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure. Sasaki S, Niwano S, Fukaya H, Yuge M, Imaki R, Inomata T, Izumi T. Int Heart J; 2007 Mar 03; 48(2):155-63. PubMed ID: 17409581 [Abstract] [Full Text] [Related]
25. Ventricular tachycardia and sudden death after primary PCI-reperfusion therapy: impact on primary prevention of sudden cardiac death. Paranskaya L, Akin I, Chatterjee T, Ritz A, Paranski P, Rehders T, Ince H, Schneider H, Nienaber CA, Bänsch D. Herzschrittmacherther Elektrophysiol; 2011 Dec 03; 22(4):243-8. PubMed ID: 22124800 [Abstract] [Full Text] [Related]
26. In-hospital and long-term outcomes among patients with spontaneous coronary artery dissection presenting with ventricular tachycardia/fibrillation. Cheung CC, Starovoytov A, Parsa A, Andrade JG, Krahn AD, Bennett M, Saw J. Heart Rhythm; 2020 Nov 03; 17(11):1864-1869. PubMed ID: 32590153 [Abstract] [Full Text] [Related]
28. Frequency and Implications of Ischemia Prior to Ventricular Tachyarrhythmia in Patients Treated With a Wearable Cardioverter Defibrillator Following Myocardial Infarction. Kandzari DE, Perumal R, Bhatt DL. Clin Cardiol; 2016 Jul 03; 39(7):399-405. PubMed ID: 27341494 [Abstract] [Full Text] [Related]
29. Microvolt T-wave alternans and electrophysiologic testing predict distinct arrhythmia substrates: implications for identifying patients at risk for sudden cardiac death. Amit G, Rosenbaum DS, Super DM, Costantini O. Heart Rhythm; 2010 Jun 03; 7(6):763-8. PubMed ID: 20156592 [Abstract] [Full Text] [Related]
30. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation. Andresen D, Steinbeck G, Brüggemann T, Haberl R, Fink L, Schröder R. Am J Cardiol; 1992 Nov 15; 70(15):1250-4. PubMed ID: 1442574 [Abstract] [Full Text] [Related]
31. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy. Rosenthal TM, Stahls PF, Abi Samra FM, Bernard ML, Khatib S, Polin GM, Xue JQ, Morin DP. Heart Rhythm; 2015 Aug 15; 12(8):1789-97. PubMed ID: 25998895 [Abstract] [Full Text] [Related]
32. Electrocardiographic parameters effectively predict ventricular tachycardia/fibrillation in acute phase and abnormal cardiac function in chronic phase of ST-segment elevation myocardial infarction. Yu Z, Chen Z, Wu Y, Chen R, Li M, Chen X, Qin S, Liang Y, Su Y, Ge J. J Cardiovasc Electrophysiol; 2018 May 15; 29(5):756-766. PubMed ID: 29399929 [Abstract] [Full Text] [Related]
37. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial. Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ, RAID Trial Investigators. J Am Coll Cardiol; 2018 Aug 07; 72(6):636-645. PubMed ID: 30071993 [Abstract] [Full Text] [Related]
38. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B. J Cardiovasc Electrophysiol; 2005 May 07; 16(5):478-82. PubMed ID: 15877617 [Abstract] [Full Text] [Related]
39. Induction of ventricular tachycardia with the fourth extrastimulus and its relationship to risk of arrhythmic events in patients with post-myocardial infarct left ventricular dysfunction. Zaman S, Kumar S, Narayan A, Sivagangabalan G, Thiagalingam A, Ross DL, Thomas SP, Kovoor P. Europace; 2012 Dec 07; 14(12):1771-7. PubMed ID: 22730377 [Abstract] [Full Text] [Related]